Prothrombin thrombophilia
Última actualización 14 de enero de 2025
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Prothrombin thrombophilia is a disorder that increases the risk of developing blood clots. Thrombophilia is the term used to describe an increased tendency to form blood clots. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. People with thrombophilia can develop clots when they are not needed. These clots can block normal blood flow and cause harm.
Selecciones de videos para Condiciones genéticasBiblioteca de videos
Descripción
Prothrombin thrombophilia is a disorder that increases the risk of developing blood clots. Thrombophilia is the term used to describe an increased tendency to form blood clots. After an injury, clots protect the body by sealing off damaged blood vessels and preventing further blood loss. People with thrombophilia can develop clots when they are not needed. These clots can block normal blood flow and cause harm.
People who have prothrombin thrombophilia have a higher-than-average risk of developing a type of clot called a deep vein thrombosis, which typically occurs in the blood vessels of the arms or legs. People with prothrombin thrombophilia also have an increased risk of developing a pulmonary embolism, which is a clot that travels through the bloodstream and lodges in the lungs.
Research suggests that pregnancy loss may be somewhat more likely in people with prothrombin thrombophilia than in those who do not have the condition. Some researchers have suggested that prothrombin thrombophilia may also increase the risk of other complications during pregnancy, though this remains controversial.
While many people with prothrombin thrombophilia will never have clotting issues, several factors increase a person's risk of blood clots. Some risk factors that contribute to the development of harmful blood clots include surgery, injury or trauma, air travel, obesity, and a family history of blood clots. Additional risk factors include pregnancy, using contraceptives such as birth control pills or patches that contain estrogen, and receiving post-menopausal hormone replacement therapy. The combination of prothrombin thrombophilia and other clotting disorders may also increase a person's risk.
Patrones de herencia
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Otros nombres
Prothrombin G20210A thrombophilia
Prothrombin-related thrombophilia
Thrombophilia 1 due to thrombin defect
Related patient information and medicines

Patient information leaflet
Trombofilia
The body has a natural clotting process in the blood, which is altered in thrombophilia. What is thrombophilia. Thrombophilia refers to a group of conditions where the blood clots more easily than normal. Inherited thrombophilias Factor V Leiden Thi... Prothrombin 20210 Prothrombin is a clotting factor, and people with the 20210 gene have a change.

Patient information leaflet
Pruebas de coagulación sanguínea
Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. For example, the 'prothrombin time' (PT) y el 'activated partial thromboplastin time' (APTT) are commonly done. Tests to check if your blood clots too easily If you have an unexplained blood clot.

Patient information leaflet
Trombosis venosa profunda
A deep vein thrombosis (DVT) is a blood clot in a vein. Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info A deep vein thrombosis (DVT) is a blood clot in a vein. Find out more here: [/health/deep-... Conditions that cause the blood to clot more easily than normal (thrombophilia) puede aumentar the risk. See the.

Patient information leaflet
sobredosis de paracetamol
They may increase later on, showing that there has been damage to the liver and that liver failure is possible. A blood clotting test (called prothrombin time) is an earlier and better indicator of hígado damage. Prothrombin time As part of the blood clotting tests that will be requested, this gives an idea of how 'thin' the blood is. The liver.

Patient information leaflet
Anticoagulantes
Anti... A mechanical heart valve. Anticoagulants stop blood clots forming on the metal heart valve, which could otherwise lead to a stroke. Certain blood conditions which make blood clots much more likely; for example, antiphospholipid syndrome Antiphospholipid syndrome or inherited thrombophilias Thrombophilia. A temporary condition that makes.

Patient information leaflet
Pruebas de función hepática
Pruebas de función hepática are a set of análisis de sangre commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. Tiempo de protrombina or International Normalised Ratio (INR). The liver performs hundreds of different functions, so there.
Lecturas adicionales y referencias
- Prothrombin thrombophilia; MedlinePlus, National Library of Medicine.
- Bosler D, Mattson J, Crisan D. Phenotypic Heterogeneity in Patients with Homozygous Prothrombin 20210AA Genotype. A paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn. 2006 Sep;8(4):420-5. doi: 10.2353/jmoldx.2006.060014.
- Kujovich JL. Prothrombin Thrombophilia. 2006 Jul 25 [updated 2021 Feb 4]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1148/
- McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med. 2002 Nov;126(11):1319-25. doi: 10.5858/2002-126-1319-CALMOT.
- Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ, Bradley LA, Prior TW, Feldman G, Popovich BW, Watson MS, Richards CS. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med. 2005 Jul-Aug;7(6):444-53. doi: 10.1097/01.gim.0000172641.57755.3a.
- Varga EA, Moll S. Cardiology patient pages. Prothrombin 20210 mutation (factor II mutation). Circulation. 2004 Jul 20;110(3):e15-8. doi: 10.1161/01.CIR.0000135582.53444.87. No abstract available.
Historial del artículo
Artículo también disponible en Inglés, Alemán, Español, Francés, Italiano, Portugués, Hindi, Hebreo, Árabe, y Sueco.
14 de enero de 2025 | Última versión
1 Ene 2025 | Publicado originalmente
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

